Previsioni di mercato per immunoistochimica in Medio Oriente e Africa fino al 2028 - Impatto del COVID-19 e analisi regionale per applicazione (diagnostica e test antidroga), prodotto (anticorpi, apparecchiature, reagenti e kit) e utente finale (ospedali e laboratori diagnostici, istituti di ricerca, e altri)

Introduzione al mercato

Gli Emirati Arabi Uniti (EAU), l\'Arabia Saudita e il Sud Africa sono i 3 principali paesi del MEA. L\'Arabia Saudita è stato il più grande mercato per l\'immunoistochimica in questa regione nel 2021. L\'Arabia Saudita è uno dei paesi in più rapida crescita nel Medio Oriente e in Africa, con una vasta popolazione malata di cancro che ne alimenta la crescita. Inoltre, l’Arabia Saudita (KSA) ha Saudi Vision 2030 che dà priorità alla prevenzione e alla promozione di nuovi modelli di cura per le malattie non trasmissibili (NCD). Inoltre, l’incidenza e la prevalenza stimate del cancro aumenteranno due volte entro il 2030 nell’Arabia Saudita. Secondo l’OMS 2018, nel Paese sono stati registrati circa 24.485 nuovi casi di cancro. Tra questi, i casi di cancro al seno sono stati circa 3.629; I casi di tumore del colon-retto sono stati 3.564. Si prevede inoltre che la presenza di laboratori che forniscono procedure diagnostiche alimenterà la crescita del mercato. Al Borg Medical Laboratories, con sede in Arabia Saudita, ad esempio, fornisce un\'ampia gamma di test di laboratorio di routine, specializzati e sub-specialistici. Offre servizi di medicina di laboratorio eccellenti e all\'avanguardia in tutto il Medio Oriente. Il piano strategico dell’Autorità saudita per gli alimenti e i farmaci (2018-2022) è stato recentemente proposto dal governo come terzo piano strategico annuale. Il progetto incorpora la visione e le priorità strategiche sviluppate dalle autorità di regolamentazione dei farmaci, degli alimenti e dei dispositivi medici. Intendono inoltre istituire un laboratorio centrale di test a Riyadh per scopi di ricerca. Inoltre, il governo prevede di spendere quasi 13,3 miliardi di dollari (50 miliardi di riyal) entro il 2020 per un’iniziativa volta a promuovere l’intrattenimento, la salute, lo sport e l’istruzione. Pertanto, l\'aumento di migliori strutture per la sanità e l\'istruzione creerà probabilmente buone opportunità per il mercato dell\'immunoistochimica.

Nel caso del COVID-19, la MEA è fortemente colpita, soprattutto il Sudafrica. Le incertezze economiche e i conflitti in corso stanno peggiorando la condizione nella regione. Ad esempio, paesi come Siria, Libia e Yemen stanno soffrendo conflitti violenti e non possono attuare solide misure di sanità pubblica. L’Iran era in profonda recessione economica a causa delle sanzioni statunitensi. Inoltre, la principale fonte di stabilizzazione economica nei paesi del Medio Oriente è la produzione e l’esportazione di petrolio. Tuttavia, la recente pandemia sta causando turbolenze alle economie del Medio Oriente. Un improvviso calo della domanda interna ed esterna di beni e prodotti, in particolare di petrolio greggio, e l\'arresto della produzione a causa della carenza di manodopera, sono i principali impatti osservati nella regione. La diffusione del coronavirus nella regione ha causato pesanti oneri agli operatori sanitari. I cardiochirurghi sono stati sovraccarichi di interventi cardiaci d’urgenza, gestione dei pazienti affetti da coronavirus e implementazione di linee guida di sicurezza per prevenire la diffusione del virus. Rapida diffusione del virus influenzato dagli interventi chirurgici elettivi. Si prevede che questi fattori ostacoleranno la crescita del mercato dell\'immunoistochimica MEA.

Panoramica e dinamiche del mercato

Il mercato dell\'immunoistochimica MEA è si prevede che crescerà da 88,98 milioni di dollari nel 2021 a 136,50 milioni di dollari entro il 2028; si stima che crescerà a un CAGR del 6,3% dal 2021 al 2028. Negli ultimi anni, l\'industria della biotecnologia si sta sviluppando a una velocità straordinariamente rapida. I produttori affrontano le diverse difficoltà sanitarie attraverso i farmaci più recenti, la digitalizzazione progressiva, le forme terapeutiche e il continuo cambiamento della gestione. Secondo le statistiche dell’Organizzazione Mondiale della Sanità (OMS), la popolazione aumenta dell’1,2% annuo, il che porta ad un aumento della popolazione nella classe anziana. L’OMS rivela inoltre che la percentuale di persone di età compresa tra 65 e 80 anni aumenterà al 28% nel 2030, rispetto al 22% nel 2000. Inoltre, la crescente urbanizzazione e un numero crescente di persone a reddito medio fanno sì che i produttori di farmaci producano farmaci ragionevoli. responsabile di guidare la crescita del mercato. Queste formulazioni sono prodotte sul mercato dopo aver superato rigide linee guida normative per la sicurezza del paziente. Ricerca e ricerca spese di sviluppo rispetto ai metodi di esplorazione, esame e produzione di prodotti innovativi, pagamenti anticipati e traguardi, miglioramento dei prodotti e dimostrazione dell\'efficienza del prodotto e della conformità normativa prima del lancio. Pertanto, si prevede che gli elevati investimenti nella ricerca da parte degli investitori e delle industrie biofarmaceutiche e biotecnologiche spingeranno la crescita del mercato dell’immunoistochimica negli anni previsti. I crescenti investimenti in attività di ricerca e sviluppo hanno aperto la strada alla crescita del settore negli anni futuri. Molti scienziati, in collaborazione con altri scienziati, offrono vari prodotti per bioreattori. Si prevede che questi fattori aumenteranno le industrie biotecnologiche e biofarmaceutiche per ottenere test efficienti che, si prevede, guideranno la crescita del mercato MEA.

Segmenti chiave del mercato

In termini di prodotto, il segmento degli anticorpi ha rappresentato la quota maggiore del mercato dell\'immunoistochimica MEA nel 2020. In termini di applicazione, il segmento della diagnostica ha detenuto una quota di mercato maggiore del mercato dell\'immunoistochimica MEA nel 2020. Ulteriori informazioni , il segmento degli ospedali e dei laboratori diagnostici deteneva una quota maggiore del mercato dell\'immunoistochimica MEA in base all\'utente finale nel 2020.

Principali fonti e aziende elencate

Alcune delle principali fonti primarie e secondarie a cui si fa riferimento per la preparazione di questo rapporto sul mercato dell\'immunoistochimica MEA sono siti Web aziendali, relazioni annuali, relazioni finanziarie, documenti governativi nazionali e database statistici, tra gli altri. Le principali società elencate nel rapporto sono Abcam plc; Agilent Technologies, Inc.; Bio SB; BIO-RAD LABORATORI INC.; Danaher; F. HOFFMANN-LA ROCHE LTD.; MERCK KGaA; PerkinElmer Inc.; e THERMO FISHER SCIENTIFIC INC.

Motivi per acquistare il rapporto

< ul>

Comprendere il panorama del mercato dell\'immunoistochimica MEA e identificare i segmenti di mercato che hanno maggiori probabilità di garantire un forte ritorno

Stare al passo con la corsa comprendendo il panorama competitivo in continua evoluzione per il mercato dell\'immunoistochimica MEA

Pianificare in modo efficiente operazioni di fusione e acquisizione e accordi di partnership nel mercato dell\'immunoistochimica MEA identificando i segmenti di mercato con le vendite probabili più promettenti

Aiuta a prendere decisioni aziendali consapevoli dall\'analisi perspicace e completa delle prestazioni del mercato di vari segmenti del mercato immunoistochimico MEA

Ottieni previsioni sui ricavi di mercato per il mercato in base ai vari segmenti dal 2021 al 2028 nella regione MEA.

Segmentazione del mercato dell\'immunoistochimica MEA

Mercato dell\'immunoistochimica MEA - Per prodotto

Attrezzatura
- Sistemi di colorazione dei vetrini
- Sistemi di microarray per tessuti
- Trattamento dei tessuti Sistemi
- Scanner per vetrini
- Altre apparecchiature
Anticorpi
- Anticorpi primari
- Anticorpi secondari
Reagenti
- Coloranti istologici
- Reagenti bloccanti e fissativi
- Substrati cromogenici
- Reagenti di fissaggio
- Stabilizzanti
- Solventi organici
- Enzimi proteolitici
- Diluenti
Kit

Mercato dell\'immunoistochimica MEA - per applicazione

Diagnostica
- Cancro
- Malattie infettive
- Malattie autoimmuni
- Diabete mellito
- Malattie nefrologiche
- Altro
Test antidroga

Mercato dell\'immunoistochimica MEA - Per utente finale

Ospedali e laboratori diagnostici
Istituti di ricerca
Altro

Mercato immunoistochimico MEA - Per paese

Emirati Arabi Uniti
Arabia Saudita
Sudafrica
Resto del MEA

Mercato dell\'immunoistochimica MEA - Profili aziendali

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 MEA Immunohistochemistry Market – By Product

1.3.2 MEA Immunohistochemistry Market – By Application

1.3.3 MEA Immunohistochemistry Market – By End User

1.3.4 MEA Immunohistochemistry Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. MEA Immunohistochemistry Market – Market Landscape

4.1 Overview

4.2 MEA PEST Analysis

4.3 Experts Opinion

5. MEA Immunohistochemistry Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Surging Incidences of Chronic and Infectious Diseases

5.1.2 Escalating R&D Investments by Biotechnology & Biopharmaceutical Companies

5.2 Key Market Restraints

5.2.1 Issues Related to Immunohistochemistry

5.3 Key Market Opportunities

5.3.1 Growing Opportunities in Emerging Countries

5.4 Future Trends

5.4.1 Rising Acceptance of Automation in Immunohistochemistry

5.5 Impact Analysis

6. Immunohistochemistry Market – MEA Analysis

6.1 MEA Immunohistochemistry Market Revenue Forecast and Analysis

7. MEA Immunohistochemistry Market Analysis– By Product

7.1 Overview

7.2 MEA Immunohistochemistry Market, By Product 2021 & 2028 (%)

7.3 Antibodies

7.3.1 Overview

7.3.2 Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.3 Primary Antibodies

7.3.3.1 Overview

7.3.3.2 Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.4 Secondary Antibodies

7.3.4.1 Overview

7.3.4.2 Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4 Equipment Market

7.4.1 Overview

7.4.2 Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.3 Slide Staining Systems

7.4.3.1 Overview

7.4.3.2 Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.4 Tissue Microarrays

7.4.4.1 Overview

7.4.4.2 Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.5 Tissue Processing Systems

7.4.5.1 Overview

7.4.5.2 Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.6 Slide Scanners

7.4.6.1 Overview

7.4.6.2 Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.7 Other Equipments

7.4.7.1 Overview

7.4.7.2 Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5 Reagents Market

7.5.1 Overview

7.5.2 Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.3 Histological Stains

7.5.3.1 Overview

7.5.3.2 Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.4 Blocking Sera & Reagents Market

7.5.4.1 Overview

7.5.4.2 Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.5 Chromogenic Substrates Market

7.5.5.1 Overview

7.5.5.2 Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.6 Stabilizers

7.5.6.1 Overview

7.5.6.2 Stabilizers Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.7 Proteolytic Enzymes

7.5.7.1 Overview

7.5.7.2 Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.8 Organic Solvents

7.5.8.1 Overview

7.5.8.2 Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.9 Fixation Reagents

7.5.9.1 Overview

7.5.9.2 Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.10 Diluents

7.5.10.1 Overview

7.5.10.2 Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.6 Kits Market

7.6.1 Overview

7.6.2 Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

8. MEA Immunohistochemistry Market Analysis – By Application

8.1 Overview

8.2 MEA Immunohistochemistry Market Share by Application 2021 & 2028 (%)

8.3 Diagnostics

8.3.1 Overview

8.3.2 Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)

8.3.3 Cancer

8.3.3.1 Overview

8.3.3.2 Cancer Market Revenue and Forecast to 2028 (US$ Mn)

8.3.4 Infectious Diseases

8.3.4.1 Overview

8.3.4.2 Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.5 Autoimmune Diseases

8.3.5.1 Overview

8.3.5.2 Autoimmune Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.6 Diabetes Mellitus

8.3.6.1 Overview

8.3.6.2 Diabetes Mellitus Market Revenue and Forecast to 2028 (US$ Mn)

8.3.7 Nephrological Diseases

8.3.7.1 Overview

8.3.7.2 Nephrological Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.8 Others

8.3.8.1 Overview

8.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Drug Testing

8.4.1 Overview

8.4.2 Drug Testing Market Revenue and Forecast to 2028 (US$ Mn)

9. MEA Immunohistochemistry Market Analysis– By End User

9.1 Overview

9.2 MEA Immunohistochemistry Market, By End User 2021 & 2028 (%)

9.3 Hospital & Diagnostic Laboratories

9.3.1 Overview

9.3.2 Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.4 Research Institutes

9.4.1 Overview

9.4.2 Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.5 Others

9.5.1 Overview

9.5.2 Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10. MEA Immunohistochemistry Market – Country Analysis

10.1 MEA Immunohistochemistry Market Revenue and Forecasts To 2028

10.1.1 MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

10.1.1.1 UAE Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.1 UAE Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.2 UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.1.2.1 UAE Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

10.1.1.1.2.2 UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.1.2.3 UAE Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

10.1.1.1.3 UAE Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.1.3.1 UAE Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

10.1.1.1.4 UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.1.2 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.1 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.2 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.2.2.1 Saudi Arabia Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

10.1.1.2.2.2 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.2.2.3 Saudi Arabia Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

10.1.1.2.3 Saudi Arabia Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.2.3.1 Saudi Arabia Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

10.1.1.2.4 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.1.3 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.1 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.2 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.3.2.1 South Africa Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

10.1.1.3.2.2 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.3.2.3 South Africa Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

10.1.1.3.3 South Africa Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.3.3.1 South Africa Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

10.1.1.3.4 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.1.4 Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.4.1 Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.4.2 Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.4.2.1 Rest of MEA Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

10.1.1.4.2.2 Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.4.2.3 Rest of MEA Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

10.1.1.4.3 Rest of MEA Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.4.3.1 Rest of MEA Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

10.1.1.4.4 Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

11. Impact Of COVID-19 Pandemic on MEA Immunohistochemistry Market

11.1 MEA: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic developments

12.3.1 Overview

13. Company Profiles

13.1 F. HOFFMANN-LA ROCHE LTD.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 MERCK KGaA

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 PerkinElmer Inc.

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 THERMO FISHER SCIENTIFIC INC.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Abcam plc

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Agilent Technologies, Inc.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 BIO-RAD LABORATORIES INC.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Danaher

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Bio SB

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. MEA Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

Table 2. UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 3. UAE Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 4. UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 5. UAE Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 6. UAE Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 7. UAE Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

Table 8. UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 9. Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 10. Saudi Arabia Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 11. Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 12. Saudi Arabia Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 13. Saudi Arabia Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 14. Saudi Arabia Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

Table 15. Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 16. South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 17. South Africa Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 18. South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 19. South Africa Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 20. South Africa Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 21. South Africa Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

Table 22. South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 23. Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 24. Rest of MEA Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 25. Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 26. Rest of MEA Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 27. Rest of MEA Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 28. Rest of MEA Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

Table 29. Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 30. Organic Developments Done By Companies

Table 31. Inorganic developments done by Companies

Table 32. Glossary of Terms

LIST OF FIGURES

Figure 1. MEA Immunohistochemistry Market Segmentation

Figure 2. MEA Immunohistochemistry Market Segmentation, By Country

Figure 3. MEA Immunohistochemistry Market Overview

Figure 4. Antibodies Segment Held the Largest Share of the Market in 2021

Figure 5. The UAE to Show Significant Growth During Forecast Period

Figure 6. MEA PEST Analysis

Figure 7. Impact Analysis of Drivers and Restraints Pertaining to MEA Immunohistochemistry Market

Figure 8. MEA Immunohistochemistry Market – Revenue Forecast and Analysis

Figure 9. MEA Immunohistochemistry Market, by Product 2021 & 2028 (%)

Figure 10. MEA Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11. MEA Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12. MEA Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13. MEA Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14. MEA Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15. MEA Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16. MEA Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17. MEA Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18. MEA Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19. MEA Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20. MEA Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21. MEA Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22. MEA Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23. MEA Stabilizer: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24. MEA Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25. MEA Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26. MEA Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27. MEA Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28. MEA Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29. MEA Immunohistochemistry Market Share by Application 2021 & 2028 (%)

Figure 30. MEA Diagnostics Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 31. MEA Cancer Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 32. MEA Infectious Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 33. MEA Autoimmune Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 34. MEA Diabetes mellitus Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 35. MEA Nephrological Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 36. MEA Others Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 37. MEA Drug Testing Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 38. MEA Immunohistochemistry Market, by End User 2021 & 2028 (%)

Figure 39. MEA Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 40. MEA Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 41. MEA Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 42. MEA Immunohistochemistry Market Revenue Overview, by Country, 2021 (US$ Mn)

Figure 43. MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

Figure 44. UAE Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 45. Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 46. South Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 47. Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 48. Impact of COVID-19 Pandemic in MEA Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MEA immunohistochemistry market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the MEA immunohistochemistry market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the immunohistochemistry market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Middle East and Africa Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and S..	May 2022
Middle East and Africa Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, En..	May 2022
Middle East and Africa In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe M..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample